Skip to content
Screener

Boston Scientific BSX Q2 2025 earnings

Reported July 23, 2025 · Before market open

Revenue$5.1BBeat by $168.0M
EPS$0.75Beat by $0.03
Revenue estimate$4.9B
EPS estimate$0.73

Next report

Oct 28, 2026 (In 3 weeks)
Revenue estimate$5.1B
EPS estimate$0.77

Financials

Q2 2025

Income statement

See full
Revenue$5.1B+22.8%
Gross profit$3.4B+20.1%
Operating income$819.0M+57.5%
Net income$795.0M+147%
EPS (diluted)$0.53+141%

Balance sheet

See full
Cash & equivalents$388.0M-51.1%
Total debt$12.0B+10.0%
Total equity$22.4B+10.0%
Total assets$41.6B+12.0%

Cash flow

See full
Operating cash flow$1.3B+58.2%
CapEx$157.0M+1.3%
Free cash flow$1.1B+71.6%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$154.04B+36.1%
Enterprise value$165.68B+34.3%
P/E61.7×-0.4×
P/S8.3×+0.9×

Profitability

See full
Gross margin68.3%-0.7pp
Operating margin17%+0.8pp
Net margin13.5%+1.5pp
FCF margin18.8%+6.8pp

Returns & leverage

See full
Return on equity11.7%+2.2pp
Debt / equity0.5×0.0×
Current ratio1.4×-0.2×

Segments

By product

See full
Electrophysiology$840.0M+96.3%
Endoscopy$737.0M+9.0%
Urology$676.0M+28.8%
Cardiac Rhythm Management$590.0M+2.4%
Watchman$486.0M+28.2%

By geography

See full
Europe, Middle East and Africa$878.0M+6.8%
Asia-Pacific$790.0M+17.9%
Latin America and Canada$169.0M+4.3%

By segment

See full
Cardiovascular$3.3B+26.8%
MedSurg$1.7B+15.7%

FAQ

When did Boston Scientific report Q2 2025 earnings?
Boston Scientific (BSX) reported Q2 2025 earnings on July 23, 2025 before market open.
What were Boston Scientific's Q2 2025 revenue and EPS?
Boston Scientific reported revenue of $5.1B and eps of $0.75 for Q2 2025.
Did Boston Scientific beat estimates in Q2 2025?
Revenue beat the consensus estimate of $4.9B by $168.0M. EPS beat the consensus estimate of $0.72 by $0.03.
How did Boston Scientific's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 22.8% from $4.1B a year earlier and eps grew 21.0% from $0.62.
Where can I find Boston Scientific's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000885725-25-000039) and the 10-Q periodic report (0000885725-25-000041) directly on SEC EDGAR. The filing index links above go to sec.gov.